At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 18 enrolled
Drug / intervention
Restalyne +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study
In Brief
A Phase 4 clinical trial evaluating Restalyne and Perlane for Infraorbital Hollows. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The primary objective of this study is to determine the efficacy and longevity of the use of Restylane® and Perlane® in combination for the rejuvenation of the infraorbital hollows and to measure patient satisfaction with this treatment
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfraorbital Hollows
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedFeb 2009
Primary CompletionSep 2009
TodayJul 2026
First PostedFeb 26, 2009
Enrollment StartFeb 1, 2009
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.3 years ago
Interventions
Restalynedrug
one syringe of Restylane® (1.0cc) will be used total for both tear trough areas.
Perlanedrug
One syringe of Perlane® (1.0cc) will be used total for both tear trough areas.